Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
It is also the second-largest pharmaceutical company by market cap in 2019. [127] Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [128] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73]
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Ross Stores suspended its dividend on May 21 due to the COVID-19 pandemic and was removed from the index prior to market open on July 1, 2020 In 2019, Chubb Limited (CB), People's United Financial (PBCT), Caterpillar Inc. (CAT), and United Technologies (UTX) were added to the index. [17]
A-Smart Holdings Ltd. Singapore. SG1CF3000008. 28 June 1999. A-Sonic Aerospace Limited. Singapore. SG1CH8000009. 17 September 2003. ABF Singapore Bond Index Fund.
A dividend tax is a tax imposed by a jurisdiction on dividends paid by a corporation to its shareholders (stockholders). The primary tax liability is that of the shareholder, though a tax obligation may also be imposed on the corporation in the form of a withholding tax. In some cases the withholding tax may be the extent of the tax liability ...
In setting dividend policy, management must pay regard to various practical considerations, [1] [2] often independent of the theory, outlined below. In general, whether to issue dividends, and what amount, is determined mainly on the basis of the company's unappropriated profit (excess cash) and influenced by the company's long-term earning power: when cash surplus exists and is not needed by ...
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...